Tempest Therapeutics, Inc. (TPST) Misses Q2 EPS by 2c

Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q2 EPS of ($0.54), $0.02 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Yum! Brands (YUM) PT Lowered to $180 at Argus